-
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares
jumped 34.3 percent to $3.55 as the company disclosed that fostamatinib, its oral spleen tyrosine kinase inhibitor, met the
primary endpoint in the final stage trial program for adult chronic/persistent immune thrombocytopenia treatment.
-
Karyopharm Therapeutics Inc (NASDAQ: KPTI) jumped
24 percent to $8.83. Jefferies upgraded Karyopharm Therapeutics from Hold to Buy and raised the price target from $9 to $12.
-
Intrepid Potash, Inc. (NYSE: IPI) shares gained 19
percent to $1.56 on news that Potash Corp. of Saskatchewan Inc. and Agrium Inc. are planning to merge.
-
Petroquest Energy Inc (NYSE: PQ) climbed 18.6 percent
to $2.80. Petroquest Energy shares have dropped 59.03 percent over the past 52 weeks, while the S&P 500 index has gained
10.56 percent in the same period.
-
Kamada Ltd (NASDAQ: KMDA) surged 18.2 percent to
$5.13 as the company disclosed favorable top-line results of its second stage trial on inhaled Alpha-1 Antitrypsin that met
primary endpoint.
-
Bonanza Creek Energy Inc (NASDAQ: BCEI) shares
climbed 17.5 percent to $1.07 after receiving a notice from the NYSE. Continued listing standards require for the stock's
trailing 30-day average closing price to stand above $1.00. The NYSE provides a six-month cure period, over which the company
plans to return to compliance, spokespeople said.
-
Ritchie Bros. Auctioneers (USA) (NYSE: RBA) shares
surged 17.1 percent to $33.82. Ritchie Bros Auctioneers announced plans to buy IronPlanet for around $758.5 million.
-
Potash Corporation of Saskatchewan (USA) (NYSE: POT)
shares gained 13.4 percent to $18.20 after the company confirmed preliminary merger discussions with Agrium Inc.
-
Phibro Animal Health Corp (NASDAQ: PAHC) shares
jumped 11.8 percent to $23.88. Phibro Animal Health posted a top and bottom line beat for Q4.
-
Orexigen Therapeutics, Inc. (NASDAQ: OREX) shares
rose 11.6 percent to $4.27 as the company reported a distribution agreement with Valeant Canada for Contrave.
-
Gemphire Therapeutics Inc (NASDAQ: GEMP) shares
rose 11.4 percent to $10.99. RBC Capital initiated coverage on Gemphire Therapeutics with an Outperform rating and a $25.00
price target, while Canaccord Genuity initiated coverage on the stock with a Buy.
-
Mosaic Co (NYSE: MOS) shares climbed 10 percent to
$30.74 on news that Potash Corp. of Saskatchewan Inc. and Agrium Inc. are planning to merge.
-
United Continental Holdings Inc (NYSE: UAL) gained
8.8 percent to $51.10 driven by the announcement that it named Scott Kirby as its new President. Kirby previously served as
American Airlines Group Inc (NASDAQ: AAL)’s
President.
-
Agrium Inc. (USA) (NYSE: AGU) rose 8 percent to
$96.56 after confirming preliminary merger discussions with Potash Corporation.
-
Tech Data Corp (NASDAQ: TECD) shares rose 5
percent to $75.85. Bank of America upgraded Tech Data from Underperform to Neutral.
-
TrueCar Inc (NASDAQ: TRUE) shares gained 3.9
percent to $9.87. B. Riley upgraded TrueCar from Sell to Neutral.
-
Mondelez International Inc (NASDAQ: MDLZ) rose
3.8 percent to $44.68 as the company said it was no longer in talks to acquire Hershey Co (NYSE: HSY) as they had found no actionable path to an agreement.
-
Barracuda Networks Inc (NYSE: CUDA) gained 3.6
percent to $23.45. Pacific Crest upgraded Barracuda Networks from Sector Weight to Overweight.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.